Meet Rob Jacobson, our new Vice President of Market Access in Oncology, and hear his motivation for joining Corcept. Interested in joining our team? Explore more career opportunities: https://lnkd.in/gG_8kxaG #WereHiring #ScienceCareers #Oncology #CortisolModulation
Corcept Therapeutics
Biotechnology Research
Redwood City, California 36,144 followers
Pioneering the discovery and development of cortisol modulators.
Über uns
At the center of discovery and development of cortisol modulation. Our mission is to unlock the potential of cortisol and revolutionize the treatment of serious diseases. For the last 25 years, we’ve led the way in the research and development of selective glucocorticoid receptors (GR) antagonists, molecules that alter GR and regulate cortisol levels. In 2012, we received FDA approval of a groundbreaking cortisol receptor blocker and the first approved treatment for hypercortisolism (Cushing’s syndrome). Today, global partnerships and collaborations form the bedrock of our robust development programs, including more than 500 GR antagonists for conditions spanning oncology, endocrine, and an array of metabolic disorders. What began as a ripple of scientific truth is now poised to unleash a sea change of discovery representing a fundamental shift in the way we understand and treat disease. We embrace possibility. We are Corcept.
- Website
-
http://www.corcept.com
External link for Corcept Therapeutics
- Industrie
- Biotechnology Research
- Größe des Unternehmens
- 201-500 Mitarbeiter
- Hauptsitz
- Redwood City, California
- Typ
- Öffentliches Unternehmen
- Gegründet
- 1998
Standorte
-
Primäre
101 Redwood Shores Pkwy
Redwood City, California 94065, US
Employees at Corcept Therapeutics
Aktualisierungen
-
Thank you, Dr. Steve Edelman, for hosting this thought-provoking discussion on Taking Control Of Your Diabetes (TCOYD) with our own Dr. Einhorn, VP of Endocrine, about the potential impact of new data on people with difficult-to-control #T2D. #Hypercortisolism #DiabetesAwareness #TakingControlOfYourDiabetes #CushingsSyndrome
-
Recognizing the signs of #CushingsSyndrome can be challenging. Learn more about one person’s path to an accurate diagnosis and treatment plan. https://lnkd.in/gS38j4EG #PatientStorytelling #Hypercortisolism #DeilesCushingsJourney
-
-
We’re studying the role of cortisol and cortisol modulation across a wide range of disease areas. Learn why: https://www.corcept.com/ #CortisolModulation #endocrinology #oncology #metabolism #neurology
-
Meet Aprille Espinueva, our Clinical Research Director of Global Metabolism. Aprille pursues her passion for clinical studies in #MASH (metabolic dysfunction-associated steatohepatitis), driving our exploration into the potential of #CortisolModulation forward. Curious about joining our team? Discover more career opportunities: https://lnkd.in/gG_8kxaG #WereHiring #ScienceCareers #Metabolics
-
For more than 12 years, we have been deeply involved with the #CushingsSyndrome patient community. Giving a voice to the patient experience is vital to ensuring their needs and values are considered at every stage of care. In this inspiring video, Deile shares her journey to diagnosis and treatment, and how it transformed her life. Thank you to Deile and the many patients whose voices go unheard, far too often. #PatientStorytelling #DeilesCushingsJourney
-
In honor of #NationalWellnessMonth, we're highlighting the extensive benefits we provide to support the health and wellbeing of our employees and their families. Our programs are designed to promote both professional success and personal fulfillment. To learn more about benefits and open roles, visit https://lnkd.in/gFWg_-yh #Hiring #OpenRoles #BiotechCareers
-
-
We recently had the opportunity to sit down with Kelly Close and the summer associates at Close Concerns to discuss #hypercortisolism and the potential impact in difficult to control #Type2Diabetes. Thank you to Kelly and the medical students for taking the time for this important issue. You are an invaluable educational resource to the diabetes community! (Subscription is required to read the full article.) https://lnkd.in/dbjGD_C #T2D #DiabetesEducation #endocrinology #DiabetesCare
Home | Close Concerns
closeconcerns.com
-
Dr. Lewis Blevins' book emphasizes the importance of broadening awareness of Cushing’s Syndrome and its diagnosis. In his latest work, the PITUITARY WORLD NEWS co-founder shares his perspective on #hypercortisolism and highlights the challenges patients face on their diagnostic journeys. You can find more information on the book here: https://lnkd.in/gZbp2v3J #endocrinology
Cushing's: a comprehensive guide to understanding a devastating disease - Pituitary World News
https://pituitaryworldnews.org
-
#Hypercortisolism in adults with difficult-to-control type 2 #diabetes might be more prevalent than previously thought. Check out this article in Healio by Michael Monostra that includes data from our CATALYST trial: https://lnkd.in/gk_WqXA2 #ADA2024 #ADAScientificSessions #T2D
Hypercortisolism prevalent among 24% of adults with difficult-to-control type 2 diabetes
healio.com
Ähnliche Seiten
Jobs durchsuchen
Finanzierung
Letzte Runde
Eigenkapital nach dem IPOUS$ 525.3K